Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Authorizes $750M Stock Repurchase Program, Notes Offering

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher today said that its board of directors has authorized a plan to repurchase $750 million of the firm's common stock.

The one-year plan would involve the firm acquiring shares of its common stock on the open market or in negotiated transactions.

Thermo Fisher said that it will offer approximately $750 million of senior notes to refinance outstanding indebtedness.

The firm has given notice of its intent to redeem all of its outstanding floating rate convertible senior debentures due 2033. The firm said that it currently has $174.1 million of those notes outstanding. The notes will be redeemed on May 10, 2010 at a price of 100 percent of their principal amount, plus accrued and unpaid interest.

In addition, proceeds from the $750 million notes offering will be used to redeem all outstanding 6-1/2 percent senior subordinated notes due 2015 at a redemption price of $1,030.63 per $1,000 on July 1, 2010. It expects to formally call those notes for redemption in May 2010. As of April 20, 2010, $500 million in aggregate principal amount of 6-1/2 percent notes is outstanding, said Thermo Fisher.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.